본문 바로가기 주메뉴 바로가기
22대 대한민국 국회 국회정보길라잡이 국회의원검색
회원가입 로그인
HOME

정보검색

소장정보 검색

국회도서관 홈으로 정보검색 소장정보 검색

결과 내 검색

동의어 포함

고급검색

인명/단체명

저자정보 상세정보
인명/단체명을 입력하세요.

키워드

  • 대표어

  • 외국어

-

초록보기

BACKGROUNDS Digital therapeutics (DTx) are software medical devices that deliver evidence-based interventions to prevent, manage, or treat disease. Their clinical value is recognised, yet economic evidence remains limited and diverse. This study aims to map and appraise the reporting quality of economic evaluations of prescription DTx and identify research gaps.

METHODS A scoping review was conducted using Tornvall’s five-stage framework. PubMed/Medline was searched for articles published up to 6 March 2025 by using “digital therap*” or “DTx” combined with economic terms (“economic ev*”, “cost*”, “saving*”). After deduplication, 237 records were screened; 16 studies reporting cost outcomes for DTx interventions were included. Two reviewers independently extracted study characteristics and assessed reporting quality with the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 checklist.

RESULTS The 16 included studies originated from the United States (81.3 %), Germany (12.5 %), and South Korea(6.2 %). ReSET-O for substance-use disorder was the most frequently evaluated product. DTx interventions usually involved smartphone or tablet applications delivering cognitive-behavioural therapy. Cost-utility analyses and cost analyses predominated; outcomes included quality-adjusted life years (QALYs), incremental cost-effectiveness rations (ICERs), and total savings. Overall, DTx were generally cost-saving or cost-effective, yet development and maintenance costs were rarely disclosed. All of the included studies were of high or moderate reporting quality, but heterogeneity in cost categories, perspectives, and time horizons limited comparability.

CONCLUSION Evidence suggests prescription DTx can deliver economic as well as clinical value, but standardized evaluations are needed. Future work should explicitly report all cost components and adopt consistent methodological standards to support reimbursement decisions and sustainable integration of DTx into health systems.

권호기사

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 목차
미국과 일본의 정신과전문약사제도 운영 현황과 시사점 = Review on the psychiatric pharmacist system in the US and Japan 여준호, 김성옥 p. 53-60
디지털치료기기의 경제성 평가 = Economic evaluation of digital therapeutics : a scoping review : 스코핑리뷰 고시연, 신채은, 김연주, 서아람, 이종영, 김혜인, 송인명 p. 61-75

추천서가 (다양한 추천 자료를 만나보세요)

권호기사보기

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 기사목차

권호

기사명 원문보기 기사목차
닫기